These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6896632)

  • 1. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
    Abreo K; Moorthy AV
    Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term evolution of membranoproliferative glomerulonephritis in adults : spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases (author's transl)].
    Droz D; Noel LH; Barbanel C; Grünfeld JP
    Nephrologie; 1982; 3(1):6-11. PubMed ID: 7088263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrastructural study on membranoproliferative glomerulonephritis with special reference to subepithelial deposits].
    Sato H
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):973-83. PubMed ID: 2263028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study.
    Lamb V; Tisher CC; McCoy RC; Robinson RR
    Lab Invest; 1977 Jun; 36(6):607-17. PubMed ID: 325295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dense intramembranous deposit disease: a clinical comparison of histological subtypes.
    Kashtan CE; Burke B; Burch G; Gustav Fisker S; Kim Y
    Clin Nephrol; 1990 Jan; 33(1):1-6. PubMed ID: 2302866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
    Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
    Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF; Jackson EC; McAdams AJ
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC; West CD; Strife CF
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases.
    Swainson CP; Robson JS; Thomson D; MacDonald MK
    J Pathol; 1983 Dec; 141(4):449-68. PubMed ID: 6363655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nail-patella syndrome: clinico-pathologic characteristics].
    Trinn C; Szöke B; Magyarlaki T; Turi S; Ormos J; Nagy J
    Orv Hetil; 1996 Oct; 137(41):2253-6. PubMed ID: 8992423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case report.
    Inaba S; Tanizawa T; Igarashi T; Higuchi A; Satou H; Mase D; Asada R; Suzuki Y; Okada T
    Clin Nephrol; 1989 Jul; 32(1):10-3. PubMed ID: 2758699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
    Taguchi T; Bohle A
    Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adults.
    Magil AB; Price JD; Bower G; Rance CP; Huber J; Chase WH
    Clin Nephrol; 1979 May; 11(5):239-44. PubMed ID: 378493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.